Infertility Testing and Treatment
This report aims to provide a comprehensive presentation of the global market for Infertility Tes ... Read More
1 IBS-C Drug Market Overview 1.1 Product Overview and Scope of IBS-C Drug 1.2 IBS-C Drug Segment by Type 1.2.1 Global IBS-C Drug Market Value Comparison by Type (2023-2029) 1.2.2 Amitiza 1.2.3 Lactulose 1.2.4 Milk of Magnesia 1.2.5 LINZESS (Linaclotide) 1.2.6 Others 1.3 IBS-C Drug Segment by Distribution Channel 1.3.1 Global IBS-C Drug Market Value by Distribution Channel: (2023-2029) 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Global IBS-C Drug Market Size Estimates and Forecasts 1.4.1 Global IBS-C Drug Revenue 2018-2029 1.4.2 Global IBS-C Drug Sales 2018-2029 1.4.3 Global IBS-C Drug Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 IBS-C Drug Market Competition by Manufacturers 2.1 Global IBS-C Drug Sales Market Share by Manufacturers (2018-2023) 2.2 Global IBS-C Drug Revenue Market Share by Manufacturers (2018-2023) 2.3 Global IBS-C Drug Average Price by Manufacturers (2018-2023) 2.4 Global IBS-C Drug Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of IBS-C Drug, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of IBS-C Drug, Product Type & Application 2.7 IBS-C Drug Market Competitive Situation and Trends 2.7.1 IBS-C Drug Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest IBS-C Drug Players Market Share by Revenue 2.7.3 Global IBS-C Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 IBS-C Drug Retrospective Market Scenario by Region 3.1 Global IBS-C Drug Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global IBS-C Drug Global IBS-C Drug Sales by Region: 2018-2029 3.2.1 Global IBS-C Drug Sales by Region: 2018-2023 3.2.2 Global IBS-C Drug Sales by Region: 2024-2029 3.3 Global IBS-C Drug Global IBS-C Drug Revenue by Region: 2018-2029 3.3.1 Global IBS-C Drug Revenue by Region: 2018-2023 3.3.2 Global IBS-C Drug Revenue by Region: 2024-2029 3.4 North America IBS-C Drug Market Facts & Figures by Country 3.4.1 North America IBS-C Drug Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America IBS-C Drug Sales by Country (2018-2029) 3.4.3 North America IBS-C Drug Revenue by Country (2018-2029) 3.4.4 U.S. 3.4.5 Canada 3.5 Europe IBS-C Drug Market Facts & Figures by Country 3.5.1 Europe IBS-C Drug Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe IBS-C Drug Sales by Country (2018-2029) 3.5.3 Europe IBS-C Drug Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific IBS-C Drug Market Facts & Figures by Country 3.6.1 Asia Pacific IBS-C Drug Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific IBS-C Drug Sales by Country (2018-2029) 3.6.3 Asia Pacific IBS-C Drug Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.6.13 Philippines 3.7 Latin America IBS-C Drug Market Facts & Figures by Country 3.7.1 Latin America IBS-C Drug Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America IBS-C Drug Sales by Country (2018-2029) 3.7.3 Latin America IBS-C Drug Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa IBS-C Drug Market Facts & Figures by Country 3.8.1 Middle East and Africa IBS-C Drug Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa IBS-C Drug Sales by Country (2018-2029) 3.8.3 Middle East and Africa IBS-C Drug Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 U.A.E 4 Segment by Type 4.1 Global IBS-C Drug Sales by Type (2018-2029) 4.1.1 Global IBS-C Drug Sales by Type (2018-2023) 4.1.2 Global IBS-C Drug Sales by Type (2024-2029) 4.1.3 Global IBS-C Drug Sales Market Share by Type (2018-2029) 4.2 Global IBS-C Drug Revenue by Type (2018-2029) 4.2.1 Global IBS-C Drug Revenue by Type (2018-2023) 4.2.2 Global IBS-C Drug Revenue by Type (2024-2029) 4.2.3 Global IBS-C Drug Revenue Market Share by Type (2018-2029) 4.3 Global IBS-C Drug Price by Type (2018-2029) 5 Segment by Distribution Channel 5.1 Global IBS-C Drug Sales by Distribution Channel (2018-2029) 5.1.1 Global IBS-C Drug Sales by Distribution Channel (2018-2023) 5.1.2 Global IBS-C Drug Sales by Distribution Channel (2024-2029) 5.1.3 Global IBS-C Drug Sales Market Share by Distribution Channel (2018-2029) 5.2 Global IBS-C Drug Revenue by Distribution Channel (2018-2029) 5.2.1 Global IBS-C Drug Revenue by Distribution Channel (2018-2023) 5.2.2 Global IBS-C Drug Revenue by Distribution Channel (2024-2029) 5.2.3 Global IBS-C Drug Revenue Market Share by Distribution Channel (2018-2029) 5.3 Global IBS-C Drug Price by Distribution Channel (2018-2029) 6 Key Companies Profiled 6.1 Allergan 6.1.1 Allergan Corporation Information 6.1.2 Allergan Description and Business Overview 6.1.3 Allergan IBS-C Drug Sales, Revenue and Gross Margin (2018-2023) 6.1.4 Allergan IBS-C Drug Product Portfolio 6.1.5 Allergan Recent Developments/Updates 6.2 Takeda 6.2.1 Takeda Corporation Information 6.2.2 Takeda Description and Business Overview 6.2.3 Takeda IBS-C Drug Sales, Revenue and Gross Margin (2018-2023) 6.2.4 Takeda IBS-C Drug Product Portfolio 6.2.5 Takeda Recent Developments/Updates 6.3 Sucampo Pharmaceuticals 6.3.1 Sucampo Pharmaceuticals Corporation Information 6.3.2 Sucampo Pharmaceuticals Description and Business Overview 6.3.3 Sucampo Pharmaceuticals IBS-C Drug Sales, Revenue and Gross Margin (2018-2023) 6.3.4 Sucampo Pharmaceuticals IBS-C Drug Product Portfolio 6.3.5 Sucampo Pharmaceuticals Recent Developments/Updates 6.4 IM HealthScience 6.4.1 IM HealthScience Corporation Information 6.4.2 IM HealthScience Description and Business Overview 6.4.3 IM HealthScience IBS-C Drug Sales, Revenue and Gross Margin (2018-2023) 6.4.4 IM HealthScience IBS-C Drug Product Portfolio 6.4.5 IM HealthScience Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 IBS-C Drug Industry Chain Analysis 7.2 IBS-C Drug Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 IBS-C Drug Production Mode & Process 7.4 IBS-C Drug Sales and Marketing 7.4.1 IBS-C Drug Sales Channels 7.4.2 IBS-C Drug Distributors 7.5 IBS-C Drug Customers 8 IBS-C Drug Market Dynamics 8.1 IBS-C Drug Industry Trends 8.2 IBS-C Drug Market Drivers 8.3 IBS-C Drug Market Challenges 8.4 IBS-C Drug Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer
List of Tables Table 1. Global IBS-C Drug Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global IBS-C Drug Market Value Comparison by Distribution Channel (2023-2029) & (US$ Million) Table 3. Global IBS-C Drug Market Competitive Situation by Manufacturers in 2022 Table 4. Global IBS-C Drug Sales (K Units) of Key Manufacturers (2018-2023) Table 5. Global IBS-C Drug Sales Market Share by Manufacturers (2018-2023) Table 6. Global IBS-C Drug Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global IBS-C Drug Revenue Share by Manufacturers (2018-2023) Table 8. Global Market IBS-C Drug Average Price (USD/Unit) of Key Manufacturers (2018-2023) Table 9. Global Key Players of IBS-C Drug, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of IBS-C Drug, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of IBS-C Drug, Product Type & Application Table 12. Global Key Manufacturers of IBS-C Drug, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global IBS-C Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IBS-C Drug as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global IBS-C Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global IBS-C Drug Sales by Region (2018-2023) & (K Units) Table 18. Global IBS-C Drug Sales Market Share by Region (2018-2023) Table 19. Global IBS-C Drug Sales by Region (2024-2029) & (K Units) Table 20. Global IBS-C Drug Sales Market Share by Region (2024-2029) Table 21. Global IBS-C Drug Revenue by Region (2018-2023) & (US$ Million) Table 22. Global IBS-C Drug Revenue Market Share by Region (2018-2023) Table 23. Global IBS-C Drug Revenue by Region (2024-2029) & (US$ Million) Table 24. Global IBS-C Drug Revenue Market Share by Region (2024-2029) Table 25. North America IBS-C Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America IBS-C Drug Sales by Country (2018-2023) & (K Units) Table 27. North America IBS-C Drug Sales by Country (2024-2029) & (K Units) Table 28. North America IBS-C Drug Revenue by Country (2018-2023) & (US$ Million) Table 29. North America IBS-C Drug Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe IBS-C Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe IBS-C Drug Sales by Country (2018-2023) & (K Units) Table 32. Europe IBS-C Drug Sales by Country (2024-2029) & (K Units) Table 33. Europe IBS-C Drug Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe IBS-C Drug Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific IBS-C Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific IBS-C Drug Sales by Region (2018-2023) & (K Units) Table 37. Asia Pacific IBS-C Drug Sales by Region (2024-2029) & (K Units) Table 38. Asia Pacific IBS-C Drug Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific IBS-C Drug Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America IBS-C Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America IBS-C Drug Sales by Country (2018-2023) & (K Units) Table 42. Latin America IBS-C Drug Sales by Country (2024-2029) & (K Units) Table 43. Latin America IBS-C Drug Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America IBS-C Drug Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa IBS-C Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa IBS-C Drug Sales by Country (2018-2023) & (K Units) Table 47. Middle East & Africa IBS-C Drug Sales by Country (2024-2029) & (K Units) Table 48. Middle East & Africa IBS-C Drug Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa IBS-C Drug Revenue by Country (2024-2029) & (US$ Million) Table 50. Global IBS-C Drug Sales (K Units) by Type (2018-2023) Table 51. Global IBS-C Drug Sales (K Units) by Type (2024-2029) Table 52. Global IBS-C Drug Sales Market Share by Type (2018-2023) Table 53. Global IBS-C Drug Sales Market Share by Type (2024-2029) Table 54. Global IBS-C Drug Revenue (US$ Million) by Type (2018-2023) Table 55. Global IBS-C Drug Revenue (US$ Million) by Type (2024-2029) Table 56. Global IBS-C Drug Revenue Market Share by Type (2018-2023) Table 57. Global IBS-C Drug Revenue Market Share by Type (2024-2029) Table 58. Global IBS-C Drug Price (USD/Unit) by Type (2018-2023) Table 59. Global IBS-C Drug Price (USD/Unit) by Type (2024-2029) Table 60. Global IBS-C Drug Sales (K Units) by Distribution Channel (2018-2023) Table 61. Global IBS-C Drug Sales (K Units) by Distribution Channel (2024-2029) Table 62. Global IBS-C Drug Sales Market Share by Distribution Channel (2018-2023) Table 63. Global IBS-C Drug Sales Market Share by Distribution Channel (2024-2029) Table 64. Global IBS-C Drug Revenue (US$ Million) by Distribution Channel (2018-2023) Table 65. Global IBS-C Drug Revenue (US$ Million) by Distribution Channel (2024-2029) Table 66. Global IBS-C Drug Revenue Market Share by Distribution Channel (2018-2023) Table 67. Global IBS-C Drug Revenue Market Share by Distribution Channel (2024-2029) Table 68. Global IBS-C Drug Price (USD/Unit) by Distribution Channel (2018-2023) Table 69. Global IBS-C Drug Price (USD/Unit) by Distribution Channel (2024-2029) Table 70. Allergan Corporation Information Table 71. Allergan Description and Business Overview Table 72. Allergan IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 73. Allergan IBS-C Drug Product Table 74. Allergan Recent Developments/Updates Table 75. Takeda Corporation Information Table 76. Takeda Description and Business Overview Table 77. Takeda IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 78. Takeda IBS-C Drug Product Table 79. Takeda Recent Developments/Updates Table 80. Sucampo Pharmaceuticals Corporation Information Table 81. Sucampo Pharmaceuticals Description and Business Overview Table 82. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 83. Sucampo Pharmaceuticals IBS-C Drug Product Table 84. Sucampo Pharmaceuticals Recent Developments/Updates Table 85. IM HealthScience Corporation Information Table 86. IM HealthScience Description and Business Overview Table 87. IM HealthScience IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 88. IM HealthScience IBS-C Drug Product Table 89. IM HealthScience Recent Developments/Updates Table 90. Key Raw Materials Lists Table 91. Raw Materials Key Suppliers Lists Table 92. IBS-C Drug Distributors List Table 93. IBS-C Drug Customers List Table 94. IBS-C Drug Market Trends Table 95. IBS-C Drug Market Drivers Table 96. IBS-C Drug Market Challenges Table 97. IBS-C Drug Market Restraints Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of IBS-C Drug Figure 2. Global IBS-C Drug Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global IBS-C Drug Market Share by Type in 2022 & 2029 Figure 4. Amitiza Product Picture Figure 5. Lactulose Product Picture Figure 6. Milk of Magnesia Product Picture Figure 7. LINZESS (Linaclotide) Product Picture Figure 8. Others Product Picture Figure 9. Global IBS-C Drug Market Value Comparison by Distribution Channel (2023-2029) & (US$ Million) Figure 10. Global IBS-C Drug Market Share by Distribution Channel in 2022 & 2029 Figure 11. Hospital Pharmacies Figure 12. Retail Pharmacies Figure 13. Online Pharmacies Figure 14. Global IBS-C Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global IBS-C Drug Market Size (2018-2029) & (US$ Million) Figure 16. Global IBS-C Drug Sales (2018-2029) & (K Units) Figure 17. Global IBS-C Drug Average Price (USD/Unit) & (2018-2029) Figure 18. IBS-C Drug Report Years Considered Figure 19. IBS-C Drug Sales Share by Manufacturers in 2022 Figure 20. Global IBS-C Drug Revenue Share by Manufacturers in 2022 Figure 21. The Global 5 and 10 Largest IBS-C Drug Players: Market Share by Revenue in 2022 Figure 22. IBS-C Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 23. Global IBS-C Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 24. North America IBS-C Drug Sales Market Share by Country (2018-2029) Figure 25. North America IBS-C Drug Revenue Market Share by Country (2018-2029) Figure 26. U.S. IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 27. Canada IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. Europe IBS-C Drug Sales Market Share by Country (2018-2029) Figure 29. Europe IBS-C Drug Revenue Market Share by Country (2018-2029) Figure 30. Germany IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. France IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. U.K. IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 33. Italy IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 34. Russia IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. Asia Pacific IBS-C Drug Sales Market Share by Region (2018-2029) Figure 36. Asia Pacific IBS-C Drug Revenue Market Share by Region (2018-2029) Figure 37. China IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. Japan IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. South Korea IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. India IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Australia IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Taiwan IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Indonesia IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Thailand IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 45. Malaysia IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 46. Philippines IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 47. Latin America IBS-C Drug Sales Market Share by Country (2018-2029) Figure 48. Latin America IBS-C Drug Revenue Market Share by Country (2018-2029) Figure 49. Mexico IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 50. Brazil IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 51. Argentina IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 52. Middle East & Africa IBS-C Drug Sales Market Share by Country (2018-2029) Figure 53. Middle East & Africa IBS-C Drug Revenue Market Share by Country (2018-2029) Figure 54. Turkey IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 55. Saudi Arabia IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 56. U.A.E IBS-C Drug Revenue Growth Rate (2018-2029) & (US$ Million) Figure 57. Global Sales Market Share of IBS-C Drug by Type (2018-2029) Figure 58. Global Revenue Market Share of IBS-C Drug by Type (2018-2029) Figure 59. Global IBS-C Drug Price (USD/Unit) by Type (2018-2029) Figure 60. Global Sales Market Share of IBS-C Drug by Distribution Channel (2018-2029) Figure 61. Global Revenue Market Share of IBS-C Drug by Distribution Channel (2018-2029) Figure 62. Global IBS-C Drug Price (USD/Unit) by Distribution Channel (2018-2029) Figure 63. IBS-C Drug Value Chain Figure 64. IBS-C Drug Production Process Figure 65. Channels of Distribution (Direct Vs Distribution) Figure 66. Distributors Profiles Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
Allergan Takeda Sucampo Pharmaceuticals IM HealthScience
This report aims to provide a comprehensive presentation of the global market for Infertility Tes ... Read More
This report aims to provide a comprehensive presentation of the global market for Intrauterine Co ... Read More
This report aims to provide a comprehensive presentation of the global market for Internet of Thi ... Read More
This report aims to provide a comprehensive presentation of the global market for IT Robotic Auto ... Read More